Resilience Therapeutics, Inc. — Form D/A

Resilience Therapeutics, Inc. of DUXBURY, MA, a company, filed a Form D amendment with the SEC on 2015-03-09. The offering totals $3.0M, of which $1.3M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2015-03-09
Form: D/A
Accession: 0001630938-15-000002
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $3.0M
Amount sold: $1.3M
Remaining: $1.7M
Investors: 18
Date of first sale: 2015-01-12
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-232603

Issuer

Name: Resilience Therapeutics, Inc.
CIK: 0001630938
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2014
Address: 536 BAY ROAD, DUXBURY, MA, 02332
Phone: 617-780-2375

Officers, directors & promoters (6)

Name	Role	Location
Jason E Fuller	Director	DUXBURY, MA
Jeffrey R Sabados	Director	DUXBURY, MA
Jeffrey R Sabados	Executive Officer	DUXBURY, MA
William M Cowan	Director	DUXBURY, MA
Retsina M Meyer	Executive Officer	Duxbury, MA
Restina M Meyer	Executive Officer	Duxbury, MA

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2016-03-03	D	$10.0M	$500K
2015-07-30	D/A	$3.0M	$2.9M
2015-06-30	D/A	$3.0M	$2.7M
2015-01-21	D	$3.0M	$925K

More